These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 5008012)

  • 1. Effects of hemodialysis on secondary hyperparathyroidism in patients with chronic renal failure.
    Johnson JW; Hattner RS; Hampers CL; Bernstein DS; Merrill JP; Sherwood LM
    Metabolism; 1972 Jan; 21(1):18-29. PubMed ID: 5008012
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperparathyroidism and renal failure.
    Arnaud CD
    Kidney Int; 1973 Aug; 4(2):89-95. PubMed ID: 4598144
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mechanisms of secondary hyperparathyroidism.
    Silver J
    Nephrol Dial Transplant; 2000; 15 Suppl 5():2-7. PubMed ID: 11073267
    [No Abstract]   [Full Text] [Related]  

  • 4. Turnover of endogenous parathyroid hormone in uremic patients and those undergoing hemodialysis.
    Massry SG; Coburn JW; Peacock M; Kleeman CR
    Trans Am Soc Artif Intern Organs; 1972; 18(0):416-22. PubMed ID: 4679896
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis.
    Pletka P; Bernstein DS; Hampers CL; Merrill JP; Sherwood LM
    Metabolism; 1974 Jul; 23(7):619-30. PubMed ID: 4600477
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating parathyroid hormone concentration in chronic renal insufficiency.
    Reiss E; Canterbury JM; Kanter A
    Arch Intern Med; 1969 Oct; 124(4):417-22. PubMed ID: 5823012
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathophysiology and treatment of renal osteodystrophy].
    Ionova D
    Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation.
    Wallfelt CH; Larsson R; Gylfe E; Ljunghall S; Rastad J; Akerström G
    World J Surg; 1988 Aug; 12(4):431-8. PubMed ID: 3420928
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular and molecular mechanisms of secondary hyperparathyroidism.
    Silver J; Levi R
    Clin Nephrol; 2005 Feb; 63(2):119-26. PubMed ID: 15730054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-producing cells exist in adipose tissues surrounding the parathyroid glands in hemodialysis patients with secondary hyperparathyroidism.
    Kakuta T; Sawada K; Kanai G; Tatsumi R; Miyakogawa T; Ishida M; Nakazawa R; Fukagawa M
    Sci Rep; 2020 Feb; 10(1):3290. PubMed ID: 32094398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and treatment of secondary hyperparathyroidism in patients with chronic renal failure.
    Tsukamoto Y
    Nephrol Dial Transplant; 1995; 10 Suppl 3():22-4. PubMed ID: 7494609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid surgery in renal failure patients.
    Dumasius V; Angelos P
    Otolaryngol Clin North Am; 2010 Apr; 43(2):433-40, x-xi. PubMed ID: 20510725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of subtotal parathyroidectomy and renal transplantation on mineral balance and secondary hyperparathyroidism in chronic renal failure.
    Johnson JW; Wachman A; Katz AI; Bernstein DS; Hampers CL; Hattner RS; Wilson RE; Merrill JP
    Metabolism; 1971 May; 20(5):487-500. PubMed ID: 4931815
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 15. Maxillary brown tumor of secondary hyperparathyroidism in a hemodialysis patient.
    Weiss RR; Schoeneman MJ; Primack W; Rozycki D; Bennett B; Greifer I
    JAMA; 1980 May; 243(19):1929-30. PubMed ID: 7365977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ultrastructural localization of aluminum in the parathyroid cells of patients on chronic dialysis].
    Galle P; Campos H; Giudicelli C
    C R Seances Acad Sci III; 1983; 296(12):545-50. PubMed ID: 6409363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of secondary hyperparathyroidism treatments on blood pressure and lipid levels in chronic renal failure patients.
    Saatci U; Akman B; Akcay A; Ozdemir FN; Budak B; Haberal M
    Transplant Proc; 2002 Sep; 34(6):2041-3. PubMed ID: 12270307
    [No Abstract]   [Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.
    Slatopolsky E; Rutherford WE; Martin K; Hruska K
    Adv Exp Med Biol; 1977; 81():467-75. PubMed ID: 899937
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease.
    Cannella G; Messa P
    Int J Artif Organs; 1999 Jan; 22(1):1-7. PubMed ID: 10098576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.